Home
Menu
Search
Search
Menu
Bioanalytical Services
LC-MS/MS & GC-MS/MS
PK/TK Services
Method Development & Validation
Quality
Quality Assurance
Data & Document Management
Training
Resources & Research
Alturas Library
Industry Resources
Regional Resources
COVID-19 Updates
Our Facility
Facility
Instrumentation
IT Infrastructure
Our Company
About Us
Our Leadership
Careers at Alturas
Philanthropy
Events
Upcoming Events
Jun
19-23
Workshop on Recent Issues in Bioanalysis (WRIB)
Jul
02
Patient Centric Sampling – What it is and how it can transform decentralised clinical trials
Jul
10-13
2023 Summer Scientific Forum
Sep
08
PBSS Workshop: Distribution and Disposition Studies for Biotherapeutics for IND / NDA Filings: Multi-specifics, ADCs, Nucleotides, Peptide conjugates, and Protein Degraders
Sep
10-13
25th North American ISSX Meeting
Sep
21
PBSS Symposium: Advances in Cancer Therapeutics
Sep
26-28
Applied Pharmaceutical Analysis (APA) 2023
Oct
06
PBSS Workshop: Human PK and Dose Prediction for Small Molecules
Oct
22-25
AAPS 2023 PharmSci 360
Jan
15
PBSS Workshop: ADME/DMPK Studies for IND and NDA Filing for Small Molecules: Nuts, Bolts and Best Practices
Past Events
Jun
04-08
71st ASMS Conference on Mass Spectrometry and Allied Topics
May
07-10
TIDES USA: Oligonucleotide & Peptide Therapeutics
Apr
24
PBSS: Preclinical Development & IND Filing for Small Molecules: Nuts, Bolts and Best Practices
Apr
23-26
2023 AAPS National Biotechnology Conference
Mar
19-23
SOT 62nd Annual Meeting and ToxExpo
Mar
12-17
39th SQA Annual Meeting & Quality College
Jan
11
AAPS eChalk Talk: Updating Regulated Assays in Anticipation of ICH M10
Dec
13
Bioanalysis Zone Coffee Chat: Reporting requirements for ICH M10
Nov
13-16
43rd Annual American College of Toxicology
Oct
16-19
2022 AAPS PharmSci 360
Sep
26-30
16th Workshop on Recent Issues in Bioanalysis
Sep
19-21
Applied Pharmaceutical Analysis 2022
May
07-10
TIDES USA: Oligonucleotide and Peptide Therapeutics
Nov
01
Development of validated LC-MS methods using surrogate matrices for the quantification of biomarkers of clinically significant drug-drug interactions
Nov
01
A Comparison of Rapid Equilibrium Dialysis with Biocompatible Solid Phase Microextraction for Plasma Protein Binding Determination using LC-MS/MS
Oct
18
Bioanalytical Perspectives on Microsampling
Oct
12
Developing a rugged chiral assay for the biomarker 2-hydroxyglutaric acid for use in routine clinical analysis of plasma samples from oncology studies
Jul
12
Are Remote Audits Here to Stay?
May
17
Highly Efficient Bioanalysis of Proteins by Immunocapture Microtips and MFLC-MS/MS
Apr
12
Quality from Home: Remote Review
Oct
12
Virtual Realities: Hosting Remote Audits (including the FDA) in a Post-COVID World
Oct
12
Ready, Willing, and Stable? Advice from the LC-MS Experts on Analysis of Unstable Compounds and Prodrugs
Sep
21
The FDA Virtually Knocks on the Door and Tips for Hosting Remote Audits
Sep
21
Using an Electronic System to Record Reagent Tracking and Solution Preparation
Jul
13
A Universal Method for the Quantitation of Multiple Oligonucleotides from Plasma by MFLC-MS/MS
Jun
16
Microsampling for Special Populations
Apr
13
An Application of Scientific Research in the Private Sector: Supporting Novel Drug Development on the Palouse
